Firstly, small molecules mimicking Smac (the physiological antagonist of IAP proteins) were designed: a Smac mimetic antagonizing XIAP was found to enhance TRAIL-induced CLL cell apoptosis [10]. Here, XIAP is linked to B-cell chronic lymphocytic leukemia.